Description of Business and Basis of Presentation (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Nov. 05, 2018 |
Sep. 21, 2017 |
Feb. 07, 2017 |
Jun. 30, 2018 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Sep. 18, 2018 |
Apr. 18, 2017 |
Dec. 31, 2016 |
|
| Stockholder's equity | $ (39,167,864) | $ (40,613,461) | $ 2,500,000 | $ (14,885,896) | |||||
| Reserve stock split, description | 1-for-500 reverse stock split | 1-for-15 reverse stock split | 1-for-30 reverse stock split | ||||||
| Common stock conversion description | As a result of the Reverse Stock Splits, every 30 shares of the Company's then outstanding common stock was combined and automatically converted into one share of the Company's common stock on February 22, 2017, every 15 shares of the Company's then outstanding common stock was combined and automatically converted into one share of the Company's common stock on October 5, 2017 and every 500 shares of the Company's common stock was combined and automatically converted into one share of the Company's common stock on November 12, 2018. | ||||||||
| Common stock shares authorized | 10,000,000,000 | 10,000,000,000 | 10,000,000,000 | ||||||
| Common stock par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||
| Preferred stock shares authorized | 5,000,000 | 5,000,000 | |||||||
| Preferred stock par value | $ 0.01 | $ 0.01 | |||||||
| Working capital deficit | $ 39,300,000 | ||||||||
| Accumulated defecit | (415,046,606) | $ (169,180,425) | |||||||
| Loss from continuing operations | (13,587,512) | (50,921,024) | |||||||
| Cash used in operating activities | (7,678,730) | (17,713,547) | |||||||
| Change in fair value of derivative instruments | 13,696,214 | (42,702,815) | |||||||
| Value of convertible liabilities | $ (12,435,250) | ||||||||
| Jamestown Regional Medical Center [Member] | |||||||||
| Cash acquired from acquisition | $ 7,600,000 | ||||||||
| Maximum [Member] | |||||||||
| Common stock par value | 0.01 | ||||||||
| Minimum [Member] | |||||||||
| Common stock par value | $ 0.0001 | ||||||||
| X | ||||||||||
- Definition Value of convertible liabilities. No definition available.
|
| X | ||||||||||
- Definition Working capital deficit. No definition available.
|
| X | ||||||||||
- Definition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of common stock conversion feature. Includes, but is not limited to, conversion price; conversion right; timing of right; terms, event or change in circumstance causing contingency to be met or adjustment to conversion price or number of shares; manner of settlement upon conversion; and method of settlement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|